Closed-end management investment company investing in the life sciences industry, primarily in the United States.
Tekla Life Sciences Investors operates as a closed-ended equity mutual fund under the management of Tekla Capital Management LLC, specializing in investments within the global life sciences sector. Established in 1992, the fund seeks opportunities in companies involved in biotechnology, pharmaceuticals, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies, as well as agriculture and environmental management industries.
The fund focuses primarily on growth stocks of small-cap companies, employing a robust investment strategy that incorporates fundamental analysis. Key factors evaluated include a company's market position, management expertise, technological advancements, and its ability to secure financing for expansion. By emphasizing growth-oriented stocks, Tekla Life Sciences Investors aims to capitalize on innovative developments and emerging trends within the life sciences sector.
Tekla Life Sciences Investors benchmarks its portfolio performance against leading indices such as the NASDAQ Biotech Index and the S&P 500 Index. These benchmarks serve as critical measures to evaluate the fund's relative performance and its ability to deliver competitive returns to investors. With its domicile in the United States, Tekla Life Sciences Investors continues to play a pivotal role in the investment landscape, providing shareholders with access to a diversified portfolio tailored to leverage growth opportunities across global life sciences markets.